GTF2IRD1 and neoplasm: BEN-mediated transcriptomic alterations have primarily been evaluated in the context of tumor resistance to therapy, and ingenuity pathway analysis revealed alterations in cell proliferation, signaling, survival and motility, which differed between BEN responsive versus resistant tumors (53).